| Charleston Physical Therapy Specialists Inc | |
|
301 R H L Blvd, Suite 202, Charleston, WV 25309-8291 | |
| (304) 746-9200 | |
| (304) 746-9202 |
| Full Name | Charleston Physical Therapy Specialists Inc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 301 R H L Blvd, Charleston, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528169976 | NPI | - | NPPES |
| 001706112 | Other | WV | MOUNTAIN STATE BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 040629 (West Virginia) | Primary |
| Provider Name | Hugh C Murray |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1184692857 PECOS PAC ID: 6305731274 Enrollment ID: I20040224000955 |
News Archive
CSL Behring announced today it has been granted national marketing authorization in Israel to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. With this most recent approval, Berinert is now licensed in 30 countries, including Europe, Japan, North America, South America and Australia.
According to the Cystic Fibrosis Foundation Patient Registry, more than 70,000 people worldwide are suffering from the disease, with approximately 1,000 new cases diagnosed each year in the United States alone.
Results of a Johns Hopkins-led study have identified a possible link between a history of sudden drops in blood pressure and the most common form of irregular heartbeat.
Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France's leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen's lab will also be a demonstration site for researchers investigating Fluidigm's technology.
› Verified 6 days ago
| Provider Name | Bobbi J Chapman |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1063480952 PECOS PAC ID: 5597653436 Enrollment ID: I20040310000929 |
News Archive
CSL Behring announced today it has been granted national marketing authorization in Israel to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. With this most recent approval, Berinert is now licensed in 30 countries, including Europe, Japan, North America, South America and Australia.
According to the Cystic Fibrosis Foundation Patient Registry, more than 70,000 people worldwide are suffering from the disease, with approximately 1,000 new cases diagnosed each year in the United States alone.
Results of a Johns Hopkins-led study have identified a possible link between a history of sudden drops in blood pressure and the most common form of irregular heartbeat.
Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France's leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen's lab will also be a demonstration site for researchers investigating Fluidigm's technology.
› Verified 6 days ago
| Provider Name | Tyler Mcgrew |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1952857690 PECOS PAC ID: 2860771581 Enrollment ID: I20161119000006 |
News Archive
CSL Behring announced today it has been granted national marketing authorization in Israel to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. With this most recent approval, Berinert is now licensed in 30 countries, including Europe, Japan, North America, South America and Australia.
According to the Cystic Fibrosis Foundation Patient Registry, more than 70,000 people worldwide are suffering from the disease, with approximately 1,000 new cases diagnosed each year in the United States alone.
Results of a Johns Hopkins-led study have identified a possible link between a history of sudden drops in blood pressure and the most common form of irregular heartbeat.
Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France's leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen's lab will also be a demonstration site for researchers investigating Fluidigm's technology.
› Verified 6 days ago
| Provider Name | Thomas Chrisley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1972296754 PECOS PAC ID: 7214397652 Enrollment ID: I20230718000912 |
News Archive
CSL Behring announced today it has been granted national marketing authorization in Israel to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. With this most recent approval, Berinert is now licensed in 30 countries, including Europe, Japan, North America, South America and Australia.
According to the Cystic Fibrosis Foundation Patient Registry, more than 70,000 people worldwide are suffering from the disease, with approximately 1,000 new cases diagnosed each year in the United States alone.
Results of a Johns Hopkins-led study have identified a possible link between a history of sudden drops in blood pressure and the most common form of irregular heartbeat.
Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France's leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen's lab will also be a demonstration site for researchers investigating Fluidigm's technology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charleston Physical Therapy Specialists Inc 301 R H L Blvd, Suite 202, Charleston, WV 25309-8291 Ph: (304) 746-9200 | Charleston Physical Therapy Specialists Inc 301 R H L Blvd, Suite 202, Charleston, WV 25309-8291 Ph: (304) 746-9200 |
News Archive
CSL Behring announced today it has been granted national marketing authorization in Israel to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. With this most recent approval, Berinert is now licensed in 30 countries, including Europe, Japan, North America, South America and Australia.
According to the Cystic Fibrosis Foundation Patient Registry, more than 70,000 people worldwide are suffering from the disease, with approximately 1,000 new cases diagnosed each year in the United States alone.
Results of a Johns Hopkins-led study have identified a possible link between a history of sudden drops in blood pressure and the most common form of irregular heartbeat.
Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France's leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen's lab will also be a demonstration site for researchers investigating Fluidigm's technology.
› Verified 6 days ago
Sarah Sturm, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 313 Maccorkle Ave Sw Ste 100, Charleston, WV 25303 Phone: 304-746-3704 Fax: 304-744-5891 | |
Scott Smolder, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Tracy Way Ste 100, Charleston, WV 25311 Phone: 304-720-0205 | |
Mrs. Mary Elizabeth Trethewey, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 699 S Park Rd, Charleston, WV 25304 Phone: 304-925-1532 | |
Adrienne J Harper, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 600 Tracy Way, Charleston, WV 25311 Phone: 304-388-4900 | |
Amy Ellison, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Association Dr, Charleston, WV 25311 Phone: 304-347-4372 | |
Nicole M Charbonniez, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Tracy Way, Charleston, WV 25311 Phone: 304-388-4900 | |
Improve Physical Therapy & Hand Center Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 4522 Maccorkle Ave Se Ste 1, Charleston, WV 25304 Phone: 304-552-8491 |